Trust the Evidence

Trust the Evidence

Share this post

Trust the Evidence
Trust the Evidence
The influence of industry over your health

The influence of industry over your health

Has Eisai forgotten the UK?

Tom Jefferson's avatar
Carl Heneghan's avatar
Tom Jefferson
and
Carl Heneghan
Sep 01, 2024
∙ Paid
58

Share this post

Trust the Evidence
Trust the Evidence
The influence of industry over your health
14
4
Share

In the fourth part of our investigation into the Miracle Biologic Lecanemab, we disclosed that the US based Alzheimer’s Association received over $750,000 from Eisai in 2023. 

Investigating the Miracle Biologic Lecanemab for Alzheimer's Disease - Part 4

Investigating the Miracle Biologic Lecanemab for Alzheimer's Disease - Part 4

Tom Jefferson and Carl Heneghan
·
August 29, 2024
Read full story

Share

Writing in the Guardian, Margaret McCartney highlighted that doctors seldom truly comprehend the extent of industry influence.

‘Data published by the Association of the British Pharmaceutical Industry (APBI) shows that almost £42m was paid to UK health professionals in 2023 – a mix of mainly consultancy, travel and conference fees. Pharma clearly thinks a massive spend is a good idea.’

The ABPI requires the industry to publish annual lists of payments to patient organisations that you can search.

In 2023, Eisai Ltd. paid out £4.47 million in the UK, of which just over £243,000 was paid to 157 healthcare professionals. Unlike McCartney, we believe these doctors fully comprehend their actions; they simply choose not to acknowledge them. What's more critical, however, is that Eisai knows they are purchasing influence a…

Keep reading with a 7-day free trial

Subscribe to Trust the Evidence to keep reading this post and get 7 days of free access to the full post archives.

Already a paid subscriber? Sign in
© 2025 Carl Heneghan
Privacy ∙ Terms ∙ Collection notice
Start writingGet the app
Substack is the home for great culture

Share